May 20 (Reuters) - The estate of Henrietta Lacks can move forward with a lawsuit against biopharmaceutical company Ultragenyx over the use of cells taken from Lacks' body in the 1950s, a Maryland federal court said on Monday. U.S. District Judge Deborah Boardman rejected Ultragenyx's motion to dismiss the case, ruling that the estate had plausibly claimed that Ultragenyx wrongly...

04:41 PM EDT, 05/20/2024 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said late Monday that David Lacey has stepped down as board chair following the conclusion of its annual stockholders' meeting. Lacey will remain on the board and will continue to chair the compensation committee and serve as a member of its development advisory committee, the company said. Nurix...

04:41 PM EDT, 05/20/2024 (MT Newswires) -- Transcat ( TRNS ) reported Q4 adjusted earnings late Monday of $0.66 per diluted share, up from $0.60 a year earlier. Three analysts polled by Capital IQ expected $0.66. Revenue for the quarter ended March 30 was $70.9 million, up from $62.1 million a year earlier. Analysts surveyed by Capital IQ expected $68.6...

04:41 PM EDT, 05/20/2024 (MT Newswires) -- Mark Scucchi, Executive Vice President & CFO, on May 16, 2024, sold 49,569 shares in Range Resources ( RRC ) for $1,829,592. Following the Form 4 filing with the SEC, Scucchi has control over a total of 213,229 shares of the company, with 213,229 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/315852/000112760224015995/xslF345X03/form4.xml ...